GLP-1 medications may affect more than appetite and weight loss. Many patients report psychological changes such as reduced cravings, altered reward responses, shifts in mood, and changes in emotional eating behaviors. In this article, we explore the potential mental health benefits and risks of GLP-1 medications, helping patients better understand how these treatments may influence both the body and the mind.

A new weight loss pill is here. FOUNDAYO (orforglipron) offers a simpler, needle-free alternative to traditional GLP-1 injections like Semaglutide and Tirzepatide. Find out how it works, how much weight you can expect to lose, and whether this new option is right for you.

GLP-1 weight loss treatments like semaglutide and tirzepatide are in high demand—but not all clinics are transparent about pricing. Some bundle medication into service fees, while others mark up drugs behind the scenes. Before starting treatment, it’s critical to understand how these programs are structured so you know exactly what you’re paying for—and what to watch out for.

Retatrutide has drawn attention for promising early results in weight-loss and metabolic research. However, it is a research-grade, non-FDA-approved compound and is not intended for routine clinical use. Products marketed outside of clinical trials may carry safety, quality, and regulatory risks. Patients should understand the difference between investigational compounds and approved therapies when considering treatment options.